Historical award
Xlcare Pharmaceuticals Inc
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (29 days old).
Fiscal year 2026: data through (29 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Potential award value
- $3,129,016.00
- Total obligated to date
- $0.00
Source date: Oct 14, 2026
Recorded work
EXERCISE 4TH AND FINAL OPTION YEAR FOR LAMIVUDINE/ZIDOVUDINE TABLETS. PERIOD OF PERFORMANCE 11/16/2024 TO 11/15/2025.
Award activity
- Obligations in covered fiscal years
- $0.00
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_IDV_36E79720D0049_3600